SAGE PRO

Home / Research / Elgi Equipments Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Elgi Equipments Limited — Q2 FY27 Results Analysis

Q2 sales grew 17%

Published · Quarter Q2 FY27 · ELGIEQUIP

PeriodQ2 FY27
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Sales

Q2 FY26₹9,680 million
Q2 FY27₹11,343 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

CHART 2

EBITDA

Q2 FY26₹1,442 million
Q2 FY27₹1,850 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

CHART 3

EBIT

Q2 FY26₹1,235 million
Q2 FY27₹1,592 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

CHART 4

PAT

Q2 FY26₹1,214 million
Q2 FY27₹1,283 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Q2 sales grew 17%

FX contributed to reported growth

Watch: Check constant currency

RESEARCH INSIGHT

Operating profit grew faster than sales

Material costs remain a headwind

Watch: Track margin

RESEARCH INSIGHT

EBIT rose from ₹1,235m to ₹1,592m

Operating earnings exclude other income

Watch: Check cost bridge

RESEARCH INSIGHT

Reported PAT increased modestly

Other income base changed

Watch: Check exceptional items

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Elgi Equipments Limited (ELGIEQUIP) — Q2 and H1 FY2027, quarter ended 30 September 2026. Consolidated results with separately identified geography and business-mix evidence.

Decision: WATCH, with a constructive cash-quality bias. Elgi reported consolidated Q2 sales of ₹11,343 million versus ₹9,680 million a year earlier, and EBITDA of ₹1,850 million versus ₹1,442 million. Its EBITDA margin rose to 16.3% from 14.9%. At September 2026 the issuer's presentation showed ₹6,990 million net cash, compared with ₹6,207 million at March 2026, even as it continued the MK2 investment programme. This makes Elgi a different investment proposition from debt-funded industrial expansion stories: cash reserves are meaningful, but the quality of revenue growth and sustainability of margins still require testing. [S1][S2]

Consolidated measure, ₹ millionQ2 FY26Q1 FY27Q2 FY27H1 FY26H1 FY27
Sales9,68010,62211,34318,34721,965
EBITDA1,4421,5531,8502,6563,403
EBIT1,2351,3061,5922,2612,898
PBT before restructuring1,6701,4681,7712,8473,239
PBT after restructuring1,6701,3951,7342,8473,129
PAT1,2141,0331,2832,0702,316

Six key decision findings

  • Q2 sales grew approximately 17.2%, from ₹9,680 million to ₹11,343 million. Management attributed about four percentage points of growth to foreign exchange, so constant-currency momentum is weaker than the headline. [S1][S2]
  • Q2 EBITDA increased approximately 28.3% from ₹1,442 million to ₹1,850 million, with a 140-basis-point published margin increase. [S2]
  • Q2 reported PAT was ₹1,283 million, versus ₹1,214 million a year earlier; it includes a ₹37 million restructuring expense above the final PBT line. [S2]
  • H1 sales reached ₹21,965 million and EBITDA ₹3,403 million, compared with ₹18,347 million and ₹2,656 million respectively. [S2]
  • Compressors represented 92% of Q2 revenue and automotive 8%; within compressors, India was 52% and rest of world 48%. These are separate mix bases. [S1][S2]
  • Net cash increased to ₹6,990 million from ₹6,207 million at March 2026; H1 cash profit and capital expenditure were presented as ₹3,374 million and ₹705 million respectively in the cash bridge. [S2]

Valuation threshold: The accepted documents do not provide a current market price or reliable comparable valuation set. No target price is manufactured. Higher conviction requires consistent organic/constant-currency compressor growth, margins resilient to material costs and tariffs, and continued positive cash generation after investment and dividends.

Chapter 1 — Investor decision and the industrial franchise

Elgi is primarily a compressor manufacturer, not a balanced compressor/automotive conglomerate. The presentation shows compressor sales at 92% of the Q2 FY27 mix, with automotive at 8%. This distinction matters when assessing demand, cyclicality and potential margins. The compressor business spans domestic and overseas markets; management said India and North America performed strongly, while European portable compressors in Italy were subdued because of weaker end markets. [S1][S2]

A cash-rich balance sheet changes the risk equation. The company is funding product development and its MK2 manufacturing programme while maintaining net cash. Nevertheless, excess cash is not a substitute for strong returns on invested capital. Investors need to understand whether new compressor products and capacity will generate sustainable contribution margins, and whether overseas growth is profitable after local selling and service costs. [S1][S2]

Decision bullets

  • The company remains 92% compressor-exposed on Q2 sales mix, so industrial compressor demand is the principal earnings driver. [S2]
  • North American and Indian growth must be separated from muted European portable-compressor demand. [S1]
  • FX contributed approximately four percentage points to reported growth, according to management; do not call the full 17% organic growth. [S1]
  • Watch net cash after capex, tax and dividends, not only quarterly EBITDA. [S2]

Chapter 2 — Earnings, restructuring and quality of profit

The consolidated presentation shows Q2 FY27 sales ₹11,343 million, material cost ₹5,579 million, employee cost ₹2,072 million and other expenses ₹1,842 million. EBITDA was ₹1,850 million and depreciation/amortisation ₹258 million, producing EBIT ₹1,592 million. Q2 FY26 comparators were sales ₹9,680 million, material cost ₹4,658 million, employee cost ₹1,944 million, other expenses ₹1,636 million, EBITDA ₹1,442 million and EBIT ₹1,235 million. [S2]

Material cost rose faster than revenue, consistent with management's observation that input costs reduced the potential profit benefit of sales growth. The call described a ₹170 million adverse material-cost effect in its EBITDA bridge, alongside a volume-growth contribution of roughly ₹650 million. Those are management's bridge figures, not independently audited causal estimates. The margin expansion reflects the net effect of volume, mix, exchange and cost control. [S1]

The company reports Q2 PBT of ₹1,771 million before restructuring, a ₹37 million exceptional restructuring expense and ₹1,734 million after restructuring. Income tax was ₹451 million and reported PAT ₹1,283 million. In Q1 the corresponding restructuring expense was ₹73 million. For H1, PBT before restructuring was ₹3,239 million and after restructuring ₹3,129 million, reflecting ₹110 million of restructuring charges. These should not be silently removed from statutory comparisons. [S2]

The Q2 FY26 PBT comparison also needs care: other income was ₹491 million in that quarter, versus ₹196 million in Q2 FY27. Management explained that a property sale influenced prior-year other income, while standalone subsidiary dividends are eliminated on consolidation. This is why a naive comparison of standalone and consolidated other income would misstate earnings quality. [S1][S2]

Earnings takeaways

  • Q2 EBITDA margin increased from 14.9% to 16.3%, despite material-cost headwinds. [S2]
  • Q2 PAT grew much more slowly than EBITDA, partly reflecting the changed other-income base and below-operating items. [S1][S2]
  • Restructuring expense of ₹37 million is real and separately disclosed; any adjusted comparison must identify it. [S2]
  • H1 EBITDA margin rose to 15.5% from 14.5%, suggesting improvement beyond one quarter. [S2]

Chapter 3 — Compressors, geography and channel economics

Compressors contributed 92% of Q2 sales, while automotive was 8%; the mix was unchanged from Q1 and close to prior-year proportions. Within compressor revenue, India contributed 52% and the rest of world 48% in Q2 FY27. The comparable Q2 FY26 compressor geography split was 48% India and 52% rest of world. These are percentages of compressor sales, not group geography shares. [S2]

Management described India as strong on both annual and sequential comparisons. North America also maintained a higher revenue trajectory. European industrial compressors improved year on year, but portable products in Italy remained weak amid the regional economic downturn. In Australia, equipment units grew while service revenue was relatively muted. These observations show why consolidated revenue can rise even as specific product/geography combinations underperform. [S1]

The presentation's sales-trend chart reports India standalone revenue of approximately ₹7,080 million in Q2 FY27 versus ₹5,682 million in Q2 FY26, and North America around ₹2,662 million versus ₹2,153 million. These are geographically scoped figures, not additional sales to add to consolidated revenue without eliminations and reconciliation. They support the management narrative of stronger India and North America. [S2]

Currency translation also matters. Management said approximately four percentage points of the group's reported 17% sales growth came from exchange movements. A sustainable operating case should therefore compare constant-currency growth and local-currency margins rather than relying on rupee sales alone. [S1]

Commercial watchpoints

  • Confirm whether India's improved share reflects volume, price or FX-adjusted demand. [S1][S2]
  • Monitor North American revenue growth against local material, tariff and distribution costs. [S1]
  • Watch the European portable-compressor slowdown separately from the industrial line. [S1]
  • Evaluate aftermarket/service profitability rather than extrapolating equipment-unit growth into service revenue. [S1]

Chapter 4 — Execution, MK2 and management Q&A

The MK2 programme is an important part of Elgi's longer-term operating plan. Management said capex was proceeding in line with the programme. That establishes execution activity, but does not prove project-level payback or future demand. The next phase of analysis should focus on commissioning milestones, cost competitiveness and whether new capacity creates measurable cash profit. [S1]

Management's EBITDA bridge offers a useful explanation of Q2 performance. It identified higher material costs as a negative contribution, while volume and exchange movements supported profit. This is a better operating narrative than attributing all EBITDA improvement to one market or assuming pricing power has permanently improved. [S1]

The analyst discussion also highlighted the difference between standalone and consolidated other income. Management explained that a prior-year property sale and subsidiary dividends affected reported line items differently. This is important for a multi-geography manufacturer: consolidated results should be the primary investment basis, with standalone numbers used only to understand the Indian operation. [S1]

Elgi's international expansion creates both optionality and execution risk. North America is improving, but Europe remains mixed. Australia shows different trends in equipment and service. Management needs to demonstrate that the installed base and local channels produce recurring service economics rather than merely higher unit shipments. [S1]

Execution tests

  • Request MK2 commissioning, spend-to-date and utilisation milestones rather than relying on a programme name. [S1]
  • Track material-cost and currency components of the EBITDA bridge in each quarter. [S1]
  • Compare standalone and consolidated profitability without double-counting intercompany dividends. [S1]
  • Demand evidence of European recovery before assuming a uniform global compressor cycle. [S1]

Chapter 5 — Cash generation, working capital, debt and investment returns

The issuer's H1 cash bridge starts with ₹6,207 million net cash at March 2026 and ends at ₹6,990 million at September 2026. It shows cash profit ₹3,374 million, a ₹336 million working-capital use, ₹694 million taxes, ₹705 million capex and ₹856 million dividend. These are presentation cash-bridge categories; they should not be relabelled as an audited free-cash-flow statement without reconciliation. [S2]

The balance-sheet bridge shows cash ₹10,550 million and debt ₹3,560 million at September, versus cash ₹10,256 million and debt ₹4,049 million at March. Net cash therefore increased by ₹783 million between these dates, consistent with the reported net cash values. The company also showed net cash ₹5,316 million at September 2025. The direction is favourable even after dividends and ongoing capex. [S2]

The H1 cash bridge reveals a useful tension. Cash profit was healthy, but taxes, dividends, working capital and capex absorbed substantial funds. Management referred to inventory as the main source of working-capital investment. A future slowdown in cash profit or rise in inventory could reduce net cash even if accounting earnings stay positive. [S1][S2]

The selected sources do not provide a plant-by-plant invested-capital schedule or a verified MK2 return-on-investment calculation. The right approach is to monitor whether incremental capex is accompanied by higher compressor volumes, margins and cash, rather than assigning a fictional payback period. [S1]

Cash tests

  • Compare net cash with the ₹6,990 million September reference on the same consolidated basis. [S2]
  • Track the ₹705 million H1 cash-bridge capex against future MK2 commissioning. [S2]
  • Monitor inventory and the ₹336 million H1 working-capital use. [S1][S2]
  • Require actual operating cash-flow and free-cash-flow reconciliations before capitalising a cash-generation multiple.

Chapter 6 — Conditional bull, base and bear scenarios

Bull case — compressor volumes and margin discipline reinforce one another. India and North America continue to expand, European weakness eases, and MK2 investments deliver efficiency gains. Material-cost pressure is offset by mix, pricing and operating leverage. EBITDA margins remain resilient and cash profit funds capex without compromising the company's net-cash position. Confirmation requires consistent local-currency demand, cash generation and new-capacity utilisation. [S1][S2]

Base case — growth moderates but balance-sheet resilience remains. Reported revenue grows, with part of the benefit coming from exchange movements; European portable demand stays soft. Margin performance remains acceptable, but material-cost inflation offsets some volume benefit. Net cash fluctuates with MK2 spending, taxes and dividends. This is a qualitative scenario, not a numerical earnings forecast.

Bear case — global demand and costs deteriorate together. Europe remains weak, North America loses momentum, raw-material inflation persists and currency tailwinds reverse. The company funds MK2 while compressor margins compress and inventory grows. The cash cushion limits immediate funding pressure but would not prevent poor incremental capital returns. No unsupported share-price downside or default probability is assigned.

Falsifiers

  • EBITDA margin reverses sharply from 16.3% without a clear temporary explanation. [S2]
  • Constant-currency revenue fails to support the reported 17% growth narrative. [S1]
  • Net cash declines materially from ₹6,990 million while capital returns remain unproven. [S2]
  • Europe portable weakness spreads to other overseas compressor businesses. [S1]
  • MK2 commissioning costs rise without matching customer demand and margins. [S1]

Chapter 7 — Investor action plan

Action: WATCH; move toward stronger conviction only after cash-backed, constant-currency operating progress. Elgi has delivered better margins and retained a substantial net-cash buffer. The most important analytical discipline is to avoid mistaking currency-assisted growth or non-recurring other income for repeatable operating improvement.

IndicatorQ2/H1 FY27 referenceNext decision question
Consolidated Q2 sales₹11,343 millionOrganic/constant-currency growth?
Consolidated Q2 EBITDA₹1,850 millionCan 16.3% margin hold?
Consolidated Q2 reported PAT₹1,283 millionWhat is cash conversion?
Q2 restructuring expense₹37 millionAre such costs recurring?
H1 sales / EBITDA₹21,965m / ₹3,403mIs improvement broad-based?
Compressor sales mix92%What is compressor volume growth?
India compressor mix52%Is local demand still outperforming?
Net cash₹6,990 millionHow does MK2 affect cash?
H1 capex₹705 million, cash bridgeIs new capacity productive?
H1 cash profit₹3,374 million, cash bridgeDoes operating cash sustain?
H1 working-capital use₹336 millionIs inventory normalising?

Next earnings-call questions

  • Quantify constant-currency sales growth, excluding the approximately four-point FX contribution described for Q2. [S1]
  • Explain compressor growth by India, North America, Europe and Australia on a consistent basis. [S1]
  • Provide the next material-cost and mix bridge against the ₹170 million Q2 management-cited cost headwind. [S1]
  • Reconcile reported PAT with restructuring expenses and other income, especially non-recurring property-sale effects. [S1][S2]
  • Show MK2 cash capex, commissioning milestones and returns, not only construction progress. [S1]
  • Reconcile net cash, dividend, inventory and tax payments with the cash-flow statement. [S2]

Specific limitations: The selected filings provide a strong consolidated P&L and a management cash bridge, but do not provide a verified project-level MK2 return schedule or current market valuation. The presentation's internal cash-bridge labels are preserved; no invented cash-flow figures or valuation forecasts have been inserted.

Original issuer/exchange filings

Financial values are in ₹ million unless explicitly described as percentages. Business mix, geographic trends, consolidated P&L and cash-bridge figures are labelled on their correct bases.

Additional company evidence

CHART 5

H1 sales

H1 FY26₹18,347 million
H1 FY27₹21,965 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

CHART 6

H1 EBITDA

H1 FY26₹2,656 million
H1 FY27₹3,403 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

CHART 7

H1 EBIT

H1 FY26₹2,261 million
H1 FY27₹2,898 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

CHART 8

H1 PAT

H1 FY26₹2,070 million
H1 FY27₹2,316 million

https://nsearchives.nseindia.com/corporate/ELGIEQUIP_06112026153841_IntimationPresentation.pdf

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure
  2. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.